Oral mucositis (OM) is a frequent and debilitating adverse effect of cancer treatments, primarily mediated by oxidative stress and inflammatory pathways involving reactive oxygen species (ROS) and nitric oxide. Photobiomodulation (PBM) therapy has emerged as a potential intervention to mitigate OM severity by regulating these mechanisms. This review examines the influence of PBM on salivary nitrite concentrations—a key biomarker of oxidative stress—in patients with OM.
Methods:
A systematic literature search was conducted across PubMed and the Cochrane Library, encompassing clinical trials published up to June 2025. Included studies investigated the effects of PBM on salivary nitrite levels in patients receiving anticancer therapy. Methodological quality was assessed using the Revised Cochrane Risk of Bias tool (RoB 2.0).
Results:
Three studies satisfied the inclusion criteria. Although variations existed among the studies regarding anticancer treatment modalities and PBM irradiation parameters, all consistently reported a reduction in salivary nitrite levels following PBM therapy.
Conclusion:
PBM therapy appears effective in alleviating OM severity, potentially attributable to its capacity to decrease salivary nitrite concentrations. Additional research is warranted to validate these preliminary findings and optimize PBM protocols for clinical implementation.
Parra-RojasS, Velázquez-CayónRT, Ciortan-PopME, MartinsMD, Cassol SpanembergJ. Preventive photobiomodulation for chemotherapy-induced oral mucositis: A systematic review of randomized clinical trials. Biomedicines, 2025; 13(2):268.
2.
PulitoC, CristaudoA, PortaCL, et al.Oral mucositis: The hidden side of cancer therapy. J Exp Clin Cancer Res, 2020; 39(1):210.
3.
de SalesPVA, GodóiIPD, de Castro BritoGA, LeitãoRC, de AraújoAA, de MedeirosCACX. Mechanisms of photobiomodulation therapy in treating and preventing antineoplastic-induced oral mucositis: A systematic review. Acta Cir Bras, 2025; 40:e403125.
4.
SonisST. A biological approach to mucositis. J Support Oncol, 2004; 2(1):21–32.
5.
SonisST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol, 2009; 45(12):1015–1020.
AlfaddaAA, SallamRM. Reactive oxygen species in health and disease. BioMed Research International, 2012; 2012(1):936486.
8.
BanerjeeS, GhoshS, MandalA, GhoshN, SilPC. ROS-associated immune response and metabolism: A mechanistic approach with implication of various diseases. Arch Toxicol, 2020; 94(7):2293–2317.
9.
LeitãoRFC, RibeiroRA, BellaguardaEAL, et al.Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol, 2007; 59(5):603–612.
10.
PaivaDL, OliveiraVR, BagnatoVS, SimõesA. Long-term survival of cancer patients after photobiomodulation therapy for prevention and treatment of oral mucositis. Photodiagnosis Photodyn Ther, 2024; 48:104248.
11.
EladS, ChengKKF, LallaRV, et al.; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 2020; 126(19):4423–4431.
12.
AttiaAMM, IbrahimFAA, Abd El-LatifNA, et al.Therapeutic antioxidant and anti‐inflammatory effects of laser acupuncture on patients with rheumatoid arthritis. Lasers Surg Med, 2016; 48(5):490–497.
13.
De MarchiT, Leal JuniorECP, BortoliC, TomazoniSS, Lopes-MartinsRÁB, SalvadorM. Low-level laser therapy (LLLT) in human progressive-intensity running: Effects on exercise performance, skeletal muscle status, and oxidative stress. Lasers Med Sci, 2012; 27(1):231–236.
14.
de OliveiraAR, VaninAA, TomazoniSS, et al.Pre-exercise infrared photobiomodulation therapy (810 nm) in skeletal muscle performance and postexercise recovery in humans: What is the optimal power output? Photomed Laser Surg, 2017; 35(11):595–603.
15.
TóthováL, KamodyovaN, ČervenkaT, CelecP. Salivary markers of oxidative stress in oral diseases. Front Cell Infect Microbiol, 2015; 5:73.
16.
PageMJ, McKenzieJE, BossuytPM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg, 2021; 88:105906.
17.
HaddawayNR, PageMJ, PritchardCC, McGuinnessLA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020‐compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev, 2022; 18(2):e1230.
18.
SalvadorDRN, SoaveDF, SaconoNT, et al.Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: A randomized clinical trial. Lasers Med Sci, 2017; 32(8):1801–1810.
19.
MartinsAFL, MoraisMO, Sousa-NetoSS, et al.The effect of photobiomodulation on nitrite and inflammatory activity in radiotherapy‐induced oral mucositis: A randomized clinical trial. Lasers Surg Med, 2021; 53(5):671–683.
20.
KhalilM, HamadahO, SaifoM. Effect of photobiomodulation on salivary nitrite in patients with chemotherapy-induced oral mucositis: A randomized clinical trial. Photobiomodul Photomed Laser Surg, 2025; 43(7):294–301.
21.
NguyenH, SanghaS, PanM, et al.Oxidative stress and chemoradiation-induced oral mucositis: A scoping review of in vitro, in vivo and clinical studies. Int J Mol Sci, 2022; 23(9):4863.
22.
KlaunigJE, KamendulisLM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol, 2004; 44(1):239–267.
23.
KlaunigJE, WangZ, PuX, ZhouS. Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol, 2011; 254(2):86–99.
24.
AbdolsamadiH, RafieianN, GoodarziMT, et al.Levels of salivary antioxidant vitamins and lipid peroxidation in patients with oral lichen planus and healthy individuals. Chonnam Med J, 2014; 50(2):58–62.
25.
BaganJ, SaezG, TormosC, et al.Oxidative stress and recurrent aphthous stomatitis. Clin Oral Investig, 2014; 18(8):1919–1923.
26.
BaganJ, SáezGT, TormosMC, et al.Oxidative stress in bisphosphonate‐related osteonecrosis of the jaws. J Oral Pathol Med, 2014; 43(5):371–377.
27.
Al‐AzriAR, GibsonRJ, BowenJM, StringerAM, KeefeDM, LoganRM. Involvement of matrix metalloproteinases (MMP‐3 and MMP‐9) in the pathogenesis of irinotecan‐induced oral mucositis. J Oral Pathology Medicine, 2015; 44(6):459–467.
28.
KhalilM, HamadahO, SaifoM. Preconditioning with photobiomodulation as an effective method in preventing chemotherapy-induced oral mucositis: A systematic review. Photobiomodul Photomed Laser Surg, 2023; 41(11):597–607.
29.
KhalilM, HamadahO, SaifoM. Photobiomodulation preconditioning for oral mucositis prevention and quality of life improvement in chemotherapy patients: A randomized clinical trial. BMC Oral Health, 2025; 25(1):190.
30.
LopesNNF, PlaplerH, ChavantesMC, LallaRV, YoshimuraEM, AlvesMTS. Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracil-induced oral mucositis in hamsters: Evaluation of two low-intensity laser protocols. Support Care Cancer, 2009; 17(11):1409–1415.
31.
LopesNNF, PlaplerH, LallaRV, et al.Effects of low‐level laser therapy on collagen expression and neutrophil infiltrate in 5‐fluorouracil‐induced oral mucositis in hamsters. Lasers Surg Med, 2010; 42(6):546–552.
32.
CurraM, PellicioliACA, FilhoNAK, et al.Photobiomodulation reduces oral mucositis by modulating NF-kB. J Biomed Opt, 2015; 20(12):125008.
33.
RupelK, ZupinL, CollivaA, et al.Photobiomodulation at multiple wavelengths differentially modulates oxidative stress in vitro and in vivo. Oxid Med Cell Longev, 2018; 2018(1):6510159.
